Nexavar Sorafenib tablets Bayer/OnyxORAL THERAPY APPROVED FOR THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA
New indications
Avelox Moxifloxacin Bayer/Schering-PloughFLUOROQUINOLONE ANTIBIOTIC APPROVED FOR CIAI
Dosing. The recommended dose of moxifloxacin is 400 mg (orally or as an IV infusion) once every 24 hours. For cIAIs, therapy should usually be initiated with the IV formulation, and the duration of therapy should last from 5 to 14 days.
